You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

PIPERAZINE CITRATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Piperazine Citrate patents expire, and when can generic versions of Piperazine Citrate launch?

Piperazine Citrate is a drug marketed by Alpharma Us Pharms, Lannett, Luitpold, and Impax Labs. and is included in four NDAs.

The generic ingredient in PIPERAZINE CITRATE is piperazine citrate. There are eighteen drug master file entries for this compound. Additional details are available on the piperazine citrate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PIPERAZINE CITRATE?
  • What are the global sales for PIPERAZINE CITRATE?
  • What is Average Wholesale Price for PIPERAZINE CITRATE?
Summary for PIPERAZINE CITRATE
Drug patent expirations by year for PIPERAZINE CITRATE

US Patents and Regulatory Information for PIPERAZINE CITRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alpharma Us Pharms PIPERAZINE CITRATE piperazine citrate SYRUP;ORAL 080774-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Impax Labs PIPERAZINE CITRATE piperazine citrate TABLET;ORAL 080874-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Lannett PIPERAZINE CITRATE piperazine citrate SYRUP;ORAL 080963-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Luitpold PIPERAZINE CITRATE piperazine citrate SYRUP;ORAL 080671-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

PIPERAZINE CITRATE Market Analysis and Financial Projection Experimental

Piperazine Citrate Market Dynamics and Financial Trajectory

Market Overview

Piperazine citrate, a derivative of the organic compound piperazine, is widely used in various industries, including pharmaceuticals, agrochemicals, and personal care. The global piperazine market, which includes piperazine citrate, is experiencing significant growth driven by increasing demand from its end-use industries.

Global Market Size and Growth

The global piperazine market was valued at approximately $543.02 million in 2024 and is forecasted to reach $743.07 million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 5.29% from 2024 to 2031[1][3][5].

Regional Market Analysis

North America

North America held the largest market share of 44.28% in 2022 and is estimated to grow with a CAGR of 4.98% during the forecast period. The region's market size was $239.04 million in 2024 and is projected to reach $321.24 million by 2030[1].

Europe

Europe accounted for a significant market share of 25.87% in 2022 and is expected to grow at a CAGR of 5.43% during the forecast period. The European market size was $140.84 million in 2024 and is forecasted to reach $194.27 million by 2030. The stable demand for agrochemicals and the growing pharmaceutical industry are key drivers in this region[1].

Asia Pacific

The Asia Pacific region held a market share of 21.08% in 2022 and is estimated to grow with a CAGR of 6.02% during the forecast period. The growth in this region is attributed to the expanding agrochemical, pharmaceutical, and chemical industries. The market size in the Asia Pacific was $116.07 million in 2024 and is projected to reach $165.5 million by 2030[1].

South America and Middle East & Africa

South America and the Middle East & Africa also contribute to the global market, with South America's market size forecasted to grow from $26.69 million in 2024 to $35.42 million by 2030, and the Middle East & Africa's market size expected to grow from $20.38 million in 2024 to $26.63 million by 2030[1].

End-Use Industry Analysis

Pharmaceuticals

The pharmaceutical industry is a major consumer of piperazine citrate, using it as an intermediate in the production of various drugs. Pharmaceutical grade piperazine accounted for around 48% of the market share in 2023 and is expected to grow significantly during the forecast period. It is used in the formulation of active pharmaceutical ingredients and as a raw material for several commercially available drugs[3].

Agrochemicals

The growing demand for pesticides and other agrochemicals is another significant driver. Piperazine is used in the production of pesticides, insecticides, and fungicides, which are essential for increasing crop yields and managing pests. The agricultural technology market, which includes these products, is estimated to grow from $357 million in 2022 to $29.56 billion by 2030[3].

Chemical Intermediates

Piperazine is widely used in the production of chemical intermediates such as amides, ethylene glycol, and other chemicals that are crucial in various industries like plastics, paper, and metals. The chemical sector's capital spending is expected to increase, with basic chemicals expanding by 4.49% and specialty chemicals by 5.28% by 2030[3].

Personal Care and Other Industries

Piperazine citrate also finds applications in personal care products, such as antiseptic and disinfectant lotions and ointments. Additionally, it is used in the production of adhesives, sealants, and other industrial chemicals[3].

Market Drivers

Growing Demand in Chemical Sector

The increasing demand for piperazine in the chemical sector is a key driver. Piperazine is used in the production of various chemical intermediates, which are essential for multiple industries[3].

Rising Demand for Pesticides

The growing population and the need for increased food production are driving the demand for agrochemicals, including pesticides that use piperazine as an ingredient[3].

Pharmaceutical Industry Growth

The pharmaceutical industry's growth, particularly in regions like Europe and Asia Pacific, is boosting the demand for pharmaceutical-grade piperazine. Investment in research and development activities in the pharmaceutical sector further supports this growth[1][3].

Market Challenges

Environmental Concerns

One of the significant challenges facing the piperazine market is the rising environmental concerns related to its production. Stringent regulations and public awareness about environmental impact can affect production costs and market dynamics[3].

Supply Chain Disruptions

The COVID-19 pandemic highlighted the vulnerability of supply chains, particularly in the pharmaceutical and agrochemical sectors. Disruptions in raw material supply and production processes can impact market growth[1].

Financial Trajectory

The financial trajectory of the piperazine citrate market is positive, with steady growth projected over the next several years. Here are some key financial metrics:

  • Global Market Size: Expected to grow from $543.02 million in 2024 to $743.07 million by 2030[1].
  • CAGR: 5.29% from 2024 to 2031[1].
  • Regional Growth: North America, Europe, and Asia Pacific are expected to see significant growth, with Asia Pacific registering the highest CAGR of 6.02% during the forecast period[1].

Key Takeaways

  • The piperazine citrate market is driven by growing demand from the pharmaceutical, agrochemical, and chemical sectors.
  • Regional markets, particularly in North America, Europe, and Asia Pacific, are expected to contribute significantly to the global market growth.
  • Environmental concerns and supply chain disruptions are key challenges that need to be addressed.
  • The market is expected to grow at a CAGR of 5.29% from 2024 to 2031.

FAQs

Q: What is the current global market size of the piperazine market? A: The global piperazine market was valued at approximately $543.02 million in 2024[1].

Q: What is the projected CAGR for the piperazine market from 2024 to 2031? A: The piperazine market is expected to grow at a CAGR of 5.29% from 2024 to 2031[1].

Q: Which region holds the largest market share in the piperazine market? A: North America holds the largest market share, accounting for 44.28% in 2022[1].

Q: What are the primary end-use industries driving the demand for piperazine? A: The primary end-use industries are pharmaceuticals, agrochemicals, and the chemical sector[3].

Q: How has the COVID-19 pandemic impacted the piperazine market? A: The pandemic led to disruptions in supply chains and production processes, affecting industries such as pharmaceuticals and agrochemicals[1].

Cited Sources

  1. Cognitive Market Research: Piperazine PIP Market Report 2024 (Global Edition)
  2. Industrial Chemicals: Piperazine: Human health tier II assessment
  3. IndustryARC: Piperazine Market Size Report, 2022-2027
  4. Dataintelo: Global Piperazine CAS 110-85-0 Market Research Report 2032
  5. Market Research Future: Piperazine Market Size, Industry Report - 2032

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.